Page 5 - Read Online
P. 5

Skoreński et al. Rare Dis Orphan Drugs J 2023;2:6                   Rare Disease and
               DOI: 10.20517/rdodj.2022.21
                                                                            Orphan Drugs Journal




               Review                                                                        Open Access



               Neutrophil serine proteases


                                             #
                              #
               Marcin Skoreński , Karolina Torzyk , Marcin Sieńczyk
               Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology,
               Wroclaw 50-370, Poland.
               #
                These authors contributed equally to this work.
               Correspondence to: Dr. Marcin Sieńczyk, Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw
               University of Science and Technology, Wybrzeze Wyspianskiego 27, Wroclaw 50-370, Poland.
               E-mail: marcin.sienczyk@pwr.edu.pl

               How to cite this article: Skoreński M, Torzyk K, Sieńczyk M. Neutrophil serine proteases. Rare Dis Orphan Drugs J 2023;2:6.
               https://dx.doi.org/10.20517/rdodj.2022.21

               Received: 4 Nov 2022  First Decision: 15 Feb 2023  Revised: 9 Mar 2023  Accepted: 20 Mar 2023  Published: 28 Mar 2023

               Academic Editors: Daniel Scherman, Brice Korkmaz  Copy Editor: Ying Han  Production Editor: Ying Han

               Abstract
               The identification and characterization of the four active neutrophil serine proteases (NSPs) have provided a better
               understanding of their roles in various physiological and pathological processes. The availability of appropriate
               tools such as substrates, inhibitors, and activity-based probes (ABPs) for studying their activity and functions in
               cells has become increasingly important. In this paper, the authors provide a comprehensive overview of the
               current knowledge on the tools available for studying NSPs. The substrates, inhibitors, and ABPs developed to date
               are described, including their strengths and limitations. The authors also discuss the potential implications of these
               tools for future research on NSPs, including their potential use in the development of new therapeutics for various
               diseases. Overall, this paper highlights the importance of understanding the activity and functions of NSPs and
               provides valuable information on the tools available for studying these proteases.

               Keywords: Neutrophils, neutrophil serine proteases (NSPs), substrates, inhibitors, activity-based probes (ABPs)



               INTRODUCTION
               Neutrophils are the most abundant group of leukocytes normally occurring in human blood, which play an
               essential role in the innate branch of the immune system. The main functions of this type of cell are to fight
                                                                                                        [1]
               infections and promote an inflammatory response to the onset of diseases caused by bacteria or fungi .






                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                           www.cdrjournal.com
   1   2   3   4   5   6   7   8   9   10